Use of nonsteroidal anti-inflammatory drugs and risk of oral cancer: a cohort study

被引：0
|
作者：
S Friis
A Poulsen
L Pedersen
J A Baron
H T Sørensen
机构：
[1] Institute of Cancer Epidemiology,Department of Genetics and Medicine
[2] Danish Cancer Society,Department of Clinical Epidemiology
[3] Aarhus University Hospital,Departments of Medicine and Community and Family Medicine
[4] Dartmouth Medical School,undefined
[5] Dartmouth College,undefined
来源：
British Journal of Cancer | 2006年 / 95卷
关键词：
nonsteroidal anti-inflammatory drugs; oral cancer; population based; risk; cohort study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Epidemiologic data regarding the chemopreventive potential of nonsteroidal anti-inflammatory drugs (NSAIDs) against oral cancer are sparse. We found a relative risk for oral cancer of 1.2 (95% CI, 1.0–1.6) among 169 589 Danish NSAID users (⩾2 prescriptions), with no apparent trends in subgroups. Our study provided no clear evidence that NSAIDs may protect against oral cancer.
引用
收藏
页码：363 / 365
页数：2
相关论文
共 50 条
  • [1] Use of nonsteroidal anti-inflammatory drugs and risk of oral cancer: a cohort study
    Friis, S.
    Poulsen, A.
    Pedersen, L.
    Baron, J. A.
    Sorensen, H. T.
    BRITISH JOURNAL OF CANCER, 2006, 95 (03) : 363 - 365
  • [2] Erratum: Use of nonsteroidal anti-inflammatory drugs and risk of oral cancer: a cohort study
    S Friis
    A Poulsen
    L Pedersen
    J A Baron
    H T Sørensen
    British Journal of Cancer, 2006, 95 : 1609 - 1609
  • [3] Use of nonsteroidal anti-inflammatory drugs and risk of oral cancer: a cohort study (vol 95, pg 363, 2006)
    Friis, S.
    Poulsen, A.
    Pedersen, L.
    Baron, J. A.
    Sorensen, H. T.
    BRITISH JOURNAL OF CANCER, 2006, 95 (11) : 1609 - 1609
  • [4] Use of Nonsteroidal Anti-inflammatory Drugs and Risk of Ovarian and Endometrial Cancer: The Multiethnic Cohort
    Setiawan, Veronica Wendy
    Matsuno, Rayna K.
    Lurie, Galina
    Wilkens, Lynne R.
    Carney, Michael E.
    Henderson, Brian E.
    Kolonel, Laurence N.
    Goodman, Marc T.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2012, 21 (09) : 1441 - 1449
  • [5] Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women
    Manon Cairat
    Marie Al Rahmoun
    Marc J. Gunter
    Gianluca Severi
    Laure Dossus
    Agnès Fournier
    Breast Cancer Research, 22
  • [6] Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women
    Cairat, Manon
    Al Rahmoun, Marie
    Gunter, Marc J.
    Severi, Gianluca
    Dossus, Laure
    Fournier, Agnes
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [7] Use of nonsteroidal anti-inflammatory drugs and risk of fractures
    Van Staa, TP
    Leufkens, HGM
    Cooper, C
    BONE, 2000, 27 (04) : 563 - 568
  • [8] Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study
    Friis, Soren
    Thomassen, Lars
    Sorensen, Henrik T.
    Tjonneland, Anne
    Overvad, Kim
    Cronin-Fenton, Deirdre R.
    Vogel, Ulla
    McLaughlin, Joseph K.
    Blot, William J.
    Olsen, Jorgen H.
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2008, 17 (02) : 88 - 96
  • [9] Nonsteroidal anti-inflammatory drug use and skin cancer risk: A prospective cohort study
    Al-Rahmoun, Marie
    Ghiasvand, Reza
    Cairat, Manon
    Mahamat-Saleh, Yahya
    Severi, Gianluca
    Boutron-Ruault, Marie-Christine
    Robsahm, Trude Eid
    Kvaskoff, Marina
    Fournier, Agnes
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 280 - 281
  • [10] Nonsteroidal anti-inflammatory drugs and prostate cancer risk
    Christine Kyme
    Nature Clinical Practice Urology, 2005, 2 (9): : 410 - 411
12345